AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 4, 2004). doi:10.1152/ajpheart.00537.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/3/H1344    most recent
00537.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gauthier, K. M
Right arrow Articles by Campbell, W. B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gauthier, K. M
Right arrow Articles by Campbell, W. B
Submitted on June 10, 2004
Accepted on November 1, 2004

ENDOTHELIUM-DERIVED 2-ARACHIDONYLGLYCEROL: AN INTERMEDIATE IN VASODILATORY EICOSANOID RELEASE IN BOVINE CORONARY ARTERIES

Kathryn M Gauthier1*, David V Baewer1, Sarah Hittner1, Cecilia J Hillard1, Kasem Nithipatikom1, D. Sudarsham Reddy1, J R Falck1, and William B Campbell1

1 Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA

* To whom correspondence should be addressed. E-mail: kgauth{at}mcw.edu.

Acetylcholine stimulates the release of endothelium-derived arachidonic acid (AA) metabolites including prostacyclin and epoxyeicosatrienoic acids, which relax coronary arteries. However, mechanisms of endothelial cell (EC) AA activation remain undefined. We propose that 2-arachidonylglycerol (2-AG) plays an important role in this pathway. An AA metabolite isolated from bovine coronary ECs was identified as 2-AG by mass spectrometry. In ECs pretreated with the fatty acid amidohydrolase inhibitor, diazomethylarachidonyl ketone (DAK, 20 µmol/L), methacholine (10 µmol/L) stimulated 2-AG release was blocked by the phospholipase C inhibitor, U73122 (10 µmol/L) or the diacylglycerol lipase inhibitor, RHC80267 (40 µmol/L). In U46619-preconstricted bovine coronary arterial rings, 2-AG relaxations averaging 100% at 10 µmol/L were inhibited by endothelium removal, DAK, the hydrolase inhibitor, methyl arachidonylfluorophosphate (10 µmol/L), the cyclooxygenase inhibitor, indomethacin (10 µmol/L) but not the CB1 cannabinoid receptor antagonist, SR141716 (1 µmol/L). The cytochrome P450 inhibitor, SKF525a (10 µmol/L) or the EET antagonist, 14,15-EEZE (10 µmol/L) further attenuated the indomethacin-resistant relaxations. The non-hydrolyzable 2-AG analogs, noladin ether, 2-AG amide and 14,15-EET glycerol amide did not induce relaxation. Nitro-L-arginine-resistance relaxations to methacholine were also inhibited by U73122, RHC80267 and DAK. 14,15-EET glycerol ester increased opening of large-conductance K+ channels 12-fold in cell-attached patches of isolated smooth muscle cells and induced relaxations averaging 95%. These results suggest that methacholine stimulates EC 2-AG production through phospholipase C and diacylglycerol lipase activation. 2-AG is further hydrolyzed to AA, which is metabolized to vasoactive eicosanoids. These studies reveal a role for 2-AG in EC AA release and the regulation of coronary tone.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Awumey, S. K. Hill, D. I. Diz, and R. D. Bukoski
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2363 - H2370.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Ghosh, H. Wang, Y. Ai, E. Romeo, J. P. Luyendyk, J. M. Peters, N. Mackman, S. K. Dey, and T. Hla
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPAR{delta} activation
J. Exp. Med., September 3, 2007; 204(9): 2053 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Batkai, M. Rajesh, P. Mukhopadhyay, G. Hasko, L. Liaudet, B. F. Cravatt, A. Csiszar, Z. Ungvari, and P. Pacher
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H909 - H918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Pacher, S. Batkai, D. Osei-Hyiaman, L. Offertaler, J. Liu, J. Harvey-White, A. Brassai, Z. Jarai, B. F. Cravatt, and G. Kunos
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H533 - H541.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.